Skip to main content
Clinical Trials/NCT06565390
NCT06565390
Recruiting
Not Applicable

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER): A Randomized Clinical Trial

University of Alabama at Birmingham1 site in 1 country700 target enrollmentSeptember 11, 2025
ConditionsEmergencies

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emergencies
Sponsor
University of Alabama at Birmingham
Enrollment
700
Locations
1
Primary Endpoint
Emergency room visits and high-acuity rehospitalizations.
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Detailed Description

To determine if among infants being discharged from the neonatal intensive care unit (NICU) without a cardiorespiratory monitor or respiratory support, remote patient monitoring using an Owlet OSS 3.0 pulse oximeter (Owlet, Lehi, UT) decreases emergency room visits and high-acuity rehospitalizations after discharge compared with routine care. Infants being discharged from the neonatal intensive care unit (NICU) without a cardiorespiratory monitor or respiratory support are eligible for inclusion. The Investigators will provide remote patient monitoring using an Owlet OSS 3.0 pulse oximeter to infants in the intervention group for a 6 month period. The Investigators will collect monthly outcome measures from caregivers of all infants.

Registry
clinicaltrials.gov
Start Date
September 11, 2025
End Date
December 31, 2030
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Colm Travers

Assistant Professor

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Infants being discharged from the NICU
  • Off all respiratory support (oxygen, CPAP, ventilator) before discharge home
  • Gestational age ≥ 22 0/7 weeks' gestation at birth
  • Parents/legal guardians have provided consent for enrollment

Exclusion Criteria

  • a major malformation, a neuromuscular condition that affects respiration or causes apnea, complex congenital heart disease and hemodynamically significant shunts, or terminal illness or decision to withhold or limit support.
  • Infants being discharged from the neonatal intensive care unit (NICU) with a cardiorespiratory monitor or respiratory support are not eligible for inclusion.

Outcomes

Primary Outcomes

Emergency room visits and high-acuity rehospitalizations.

Time Frame: 6 months

Number of emergency room visits and high-acuity rehospitalizations.

Secondary Outcomes

  • Number of participants with serious outcome events(6 months)
  • High-acuity rehospitalizations(6 months)
  • Apparent life-threatening event (ALTE/ Brief resolved unexplained event (BRUE)(6 months)
  • Caregiver anxiety score.(6 months)
  • All-cause mortality.(6 months)
  • Other rehospitalizations(6 months)
  • Safe-sleep practice adherence(6 months)
  • Caregiver sleep disturbance.(6 months)
  • Sick visits(6 months)
  • Healthcare utilization(6 months)
  • Emergency room visits(6 months)

Study Sites (1)

Loading locations...

Similar Trials